Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.
Dimitrova EG, Chaushev BG, Conev NV, Kashlov JK, Zlatarov AK, Petrov DP, Popov HB, Stefanova NT, Klisarova AD, Bratoeva KZ, Donev IS. Dimitrova EG, et al. Biosci Trends. 2017 May 23;11(2):221-228. doi: 10.5582/bst.2016.01205. Epub 2017 Feb 28. Biosci Trends. 2017. PMID: 28250335 Free article.
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Petrova MP, Eneva MI, Arabadjiev JI, Conev NV, Dimitrova EG, Koynov KD, Karanikolova TS, Valev SS, Gencheva RB, Zhbantov GA, Ivanova AI, Sarbianova II, Timcheva CV, Donev IS. Petrova MP, et al. Biosci Trends. 2020 Mar 16;14(1):48-55. doi: 10.5582/bst.2019.01279. Epub 2020 Feb 4. Biosci Trends. 2020. PMID: 32023563 Free article.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Petrova MP, Donev IS, Radanova MA, Eneva MI, Dimitrova EG, Valchev GN, Minchev VT, Taushanova MS, Boneva MV, Karanikolova TS, Gencheva RB, Zhbantov GA, Ivanova AI, Timcheva CV, P Pavlov B, Megdanova VG, Robev BS, Conev NV. Petrova MP, et al. Among authors: dimitrova eg. Clin Exp Immunol. 2020 Dec;202(3):353-362. doi: 10.1111/cei.13505. Epub 2020 Aug 26. Clin Exp Immunol. 2020. PMID: 32757277 Free PMC article.
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.
Gencheva R, Petrova M, Kraleva P, Hadjidekova S, Radanova M, Conev N, Stoyanov D, Arabadjiev J, Tazimova E, Bachurska S, Eneva M, Tsvetkova M, Zhbantov G, Karanikolova T, Manov D, Ivanova A, Taushanova-Hadjieva M, Staneva R, Dimitrova E, Donev I. Gencheva R, et al. Among authors: dimitrova e. Cancer Rep (Hoboken). 2023 Dec 26;7(2):e1966. doi: 10.1002/cnr2.1966. Online ahead of print. Cancer Rep (Hoboken). 2023. PMID: 38148576 Free PMC article.
A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values.
Dancheva Z, Chausheva S, Stoeva T, Dyankova M, Yordanova T, Chaushev B, Marinov R, Nikolov V, Abushev P, Todorov G, Dimitrova E, Klisarova A, Anakievski D. Dancheva Z, et al. Among authors: dimitrova e. Hell J Nucl Med. 2024 Jan-Apr;27(1):16-26. doi: 10.1967/s002449912702. Epub 2024 Apr 18. Hell J Nucl Med. 2024. PMID: 38629815 Free article.
The PNUTS phosphatase complex controls transcription pause release.
Kelley JR, Dimitrova E, Maciuszek M, Nguyen HT, Szczurek AT, Hughes AL, Blackledge NP, Kettenbach AN, Klose RJ. Kelley JR, et al. Among authors: dimitrova e. Mol Cell. 2024 Dec 19;84(24):4843-4861.e8. doi: 10.1016/j.molcel.2024.10.045. Epub 2024 Nov 26. Mol Cell. 2024. PMID: 39603239 Free article.
164 results